EXTRACELLULAR VESICLES (EVs)
Natural Cellular Communication
Unique Therapeutic Potential
conditioned media and biological fluid samples has led to the development of specialized technology that improves the isolation of exosomes from heterogeneous colloidal suspensions containing EVs and other biomolecules. Cell engineering and EV modification can further facilitate exosome isolation and improve the bioactivity of engineered exosomes, as well as their ability to target specific cells involved in disease and injury. Exosome research with a focus on clinical applications has and will continue to enable the optimization of therapeutic agents for specific clinical indications.
Developing the Potential of EVs
The biological properties of EV will be developed into future diagnostics, more effective therapeutics and innovative regenerative products for improved health and longevity. Examining the biomolecular profile of EVs in biological fluid samples in health and disease using advanced EV analytical techniques and deep learning algorithms will enable earlier and more accurate detection of disease and injury without the morbidity of current diagnostic methods. Bioengineering enhancements to the natural biological activity of EVs will optimize targeted exosome therapeutics for challenging clinical conditions.
Designing biocompatible carriers and delivery systems will also augment the stability and efficacy of engineered exosomes. Development of simple, safe, effective regenerative products using these combined EV technologies will revolutionize medicine, providing non-invasive solutions to difficult clinical problems. By extension of this technology to disease prevention and general wellness, EV Biologics hopes to change the face of modern diagnostics and therapeutics, as well as general health and wellness.